Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension
Mendelian Randomization
Proteome
DOI:
10.1164/rccm.202109-2106oc
Publication Date:
2022-04-08T15:31:10Z
AUTHORS (118)
ABSTRACT
Rationale: Pulmonary arterial hypertension (PAH) is characterized by structural remodeling of pulmonary arteries and arterioles. Underlying biological processes are likely reflected in a perturbation circulating proteins. Objectives: To quantify analyze the plasma proteome patients with PAH using inherited genetic variation to inform on underlying molecular drivers. Methods: An aptamer-based assay was used measure proteins 357 idiopathic or heritable PAH, 103 healthy volunteers, 23 relatives PAH. In discovery replication subgroups, proteomes individuals were compared, relationship transplantation-free survival determined. examine causal relationships protein quantitative trait loci (pQTL) that influenced levels patient population as instruments for Mendelian randomization (MR) analysis. Measurements Main Results: From 4,152 annotated proteins, 208 differed between subjects, 49 predicted long-term survival. MR based cis-pQTL located proximity encoding gene prognostic distinguished from health estimated an adverse effect higher netrin-4 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.16–2.08) protective thrombospondin-2 (OR, 0.83; CI, 0.74–0.94) Both tracked development previously changes associated pressure at disease onset. Conclusions: Integrated analysis genome implicates two secreted matrix-binding thrombospondin-2, pathobiology
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (33)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....